Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_assertion type Assertion NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_head.
- NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_assertion description "[Although IFG fully inhibits GlcCerase in the lysosome in an in situ assay, washout of the drug leads to partial recovery of GlcCerase activity within 4 h and full recovery by 24 h. These findings provide support for the possible use of active-site inhibitors in the treatment of some forms of Gaucher disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.
- NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_assertion evidence source_evidence_literature NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.
- NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_assertion SIO_000772 16945909 NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.
- NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_assertion wasDerivedFrom befree-2016 NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.
- NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_assertion wasGeneratedBy ECO_0000203 NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.